Stock listing
NASDAQ:VIVO Meridian Bioscience Inc Stock
Follow Meridian Bioscience Inc into a list and get an email when it puts out news.
Last close · NASDAQ:VIVO
$33.97 USD
Close on Jan 31, 2023 · No longer trades
- Lowest – highest close
- $5.55 – $35.90 USDSince May 14, 2007 · lowest Mar 12, 2020 · highest Apr 8, 2008
Delisted NASDAQ:VIVO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:VIVO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Meridian Bioscience Inc on 6ix
- Decks
- 15 decks · latest Jul 7, 2022
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Oct 29, 2026 | −16.5% |
| Quarter to Jun 30, 2022 | Sep 15, 2022 · After close | −3.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (July 2022) | Merger or acquisition | 11 slides | Jul 7, 2022 |
| Q2 FY2022 Earnings Presentation | Earnings | 13 slides | May 6, 2022 |
| Q1 FY2022 Earnings Presentation | Earnings | 15 slides | Feb 4, 2022 |
| Q4 FY2021 Earnings Presentation | Earnings | 17 slides | Nov 12, 2021 |
| Q3 FY2021 Earnings Presentation | Earnings | 15 slides | Aug 6, 2021 |
| Q2 FY2021 Earnings Presentation | Earnings | 9 slides | May 7, 2021 |
| Q1 FY2021 Earnings Presentation | Earnings | 11 slides | Feb 5, 2021 |
| FY2020 Earnings Presentation | Earnings | 16 slides | Nov 13, 2020 |
| Q3 FY2020 Earnings Presentation | Earnings | 13 slides | Aug 7, 2020 |
| Q2 FY2020 Earnings Presentation | Earnings | 20 slides | May 8, 2020 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2019 Earnings Presentation | Earnings | 24 slides | Nov 7, 2019 |
| William Blair Healthcare Conference 2019 | Conference | 26 slides | Jun 6, 2019 |
| Q1 FY2019 Earnings Presentation | Earnings | 12 slides | Jan 24, 2019 |
| FY2018 Earnings Presentation | Earnings | 29 slides | Nov 8, 2018 |
| Sidoti & Company Fourteenth Annual New York Growth Institutional Investor Forum (March 2010) | Conference | 12 slides | Mar 23, 2010 |
Cap table
Built by 6ix from Meridian Bioscience Inc’s releases · as of Jun 30, 2026
- Common shares
- 31,993,555
- Fully diluted
- 31,993,555
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 31,993,555 | Jun 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 31,993,555 |
| Jun 30, 2026 | 19,456,000 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felicia Williams Other companies: NeoGenomics, Inc. (Board Member · Since at least Nov 1, 2024); Anywhere Real Estate Inc (Director · Since at least Mar 18, 2021); Paycom Software, Inc. (Director · May 9, 2022 – May 5, 2025 · Past); Macy's Inc (SVP,Controller/ERM & Int. CFO · Jun 1, 2016 – Jul 9, 2020 · Past) | Director · Sep 20, 2018 – Jan 31, 2023 · Past |
| Andrew S Kitzmiller Other companies: Hillenbrand Inc (VP, CAO and Controller · Nov 21, 2019 – Dec 30, 2021 · Past) | Executive Vice President & CFO · Feb 21, 2022 – Jan 31, 2023 · Past |
| David Phillips Other companies: Cintas Corporation (Director · Oct 10, 2006 – Oct 18, 2011 · Past) | Director · Jan 19, 2006 – Jan 12, 2022 · Past |
| John McIlwraith | Director · Jan 29, 2020 – Jan 31, 2023 · Past |
| Julie Diana Smith | Sr VP, Controller, PAO · Sep 16, 2022 – Jan 31, 2023 · Past |
| Marviette D Johnson | VP, Human Resources · Apr 21, 2011 – Mar 2, 2015 · Past |
| Susan Rolih | EVP, Global Reg & Quality Syst · Nov 4, 2015 – Nov 15, 2018 · Past |
| Tony Serafini-Lamanna | Executive VP-Diagnostics · Nov 5, 2020 – Jan 31, 2023 · Past |
Log in to ask 6ix AI your own questions about Meridian Bioscience Inc.